COST-EFFECTIVENESS COMPARISON OF BOTULINUM TOXIN TYPE A PLUS BEST SUPPORTIVE CARE VERSUS BEST SUPPORTIVE CARE ALONE IN THE TREATMENT OF IDIOPATHIC OVERACTIVE BLADDER WITH URINARY INCONTINENCE AMONG PATIENTS NOT ADEQUATELY MANAGED BY ANTICHOLINERGIC THERAPY IN FRANCE

被引：1
|
作者：
Ruffion, A. [1 ]
Velard, M. [2 ]
Loveman, C. [3 ]
Khalaf, K. [4 ]
Roze, S. [5 ]
Pignata, M. [5 ]
Stanisic, S. [6 ]
Lister, J. [7 ]
机构：
[1] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France
[2] Allergan France SAS, Courbevoie, France
[3] Allergan Holdings Ltd, Marlow, Bucks, England
[4] Allergan Pharmaceut Inc, Irvine, CA USA
[5] HEVA HEOR, Lyon, France
[6] LASER Grp, Milan, Italy
[7] LASER ANALYT, Lorrach, Germany
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.1330
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PUK22
引用
收藏
页码：A470 / A470
页数：1
相关论文
共 50 条
  • [1] OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales
    Freemantle, Nick
    Khalaf, Kristin
    Loveman, Clara
    Stanisic, Sanja
    Gultyaev, Dmitry
    Lister, Johanna
    Drake, Marcus
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2016, 17 (07): : 911 - 921
  • [2] OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales
    Nick Freemantle
    Kristin Khalaf
    Clara Loveman
    Sanja Stanisic
    Dmitry Gultyaev
    Johanna Lister
    Marcus Drake
    The European Journal of Health Economics, 2016, 17 : 911 - 921
  • [3] Cost-Effectiveness of Avelumab Maintenance Therapy Plus Best Supportive Care vs. Best Supportive Care Alone for Advanced or Metastatic Urothelial Carcinoma
    Xie, Qian
    Zheng, Hanrui
    Chen, Ye
    Peng, Xingchen
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [4] COST-EFFECTIVENESS OF ORAL TOPOTECAN PLUS BEST SUPPORTIVE CARE VERSUS BEST SUPPORTIVE CARE ALONE IN PATIENTS WITH RELAPSED SMALL-CELL LUNG CANCER (SCLC) IN THE UK
    Lykopoulos, K.
    Morris, S.
    Papo, N.
    O'Brien, M. E.
    VALUE IN HEALTH, 2008, 11 (06) : A482 - A482
  • [5] Cost-effectiveness of oral topotecan plus best supportive care versus best supportive care alone in patients with relapsed small-cell lung cancer (SCLC) in the UK
    O'Brien, Mary E.
    Morris, Stephen
    Papo, Natalie L.
    Lykopoulos, Konstantinos
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S818 - S818
  • [6] A cost-effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first-line maintenance treatment for patients with locally advanced or metastatic urothelial carcinoma in Taiwan
    Su, Po-Jung
    Xiao, Ying
    Lin, Amy Y.
    Goh, Connie
    Wu, Ethan
    Liu, Kevin
    Chou, Patrick
    Kuo, Kaitlin
    Palencia, Roberto
    Chang, Jane
    Kearney, Mairead
    Kapetanakis, Venediktos
    Benedict, Agnes
    CANCER REPORTS, 2023,
  • [7] Cost-effectiveness of abobotulinumtoxinA plus best supportive care compared with best supportive care alone for early treatment of adult lower limb spasticity following an acute event
    Moore, Peter
    Danchenko, Natalya
    Weidlich, Diana
    Tijerina, Alejandra Rodarte
    PLOS ONE, 2024, 19 (02):
  • [8] Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma (vol 10, 837854, 2022)
    Xie, Qian
    Zheng, Hanrui
    Chen, Ye
    Peng, Xingchen
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [9] Cost-effectiveness analysis of capecitabine maintenance therapy plus best supportive care vs. best supportive care alone as first-line treatment of newly diagnosed metastatic nasopharyngeal carcinoma
    Han, Jiaqi
    Lan, Xiaomeng
    Tian, Kun
    Shen, Xi
    He, Jinlan
    Chen, Nianyong
    FRONTIERS IN PUBLIC HEALTH, 2023, 10
  • [10] BOTOX, NERVE STIMULATION DEVICES, MIRABEGRON, AND ANTICHOLINERGICS VERSUS BEST SUPPORTIVE CARE FOR OVERACTIVE BLADDER: AN UPDATED US COST-EFFECTIVENESS ANALYSIS
    Murray, Brian
    Miles-Thomas, Jennifer
    Sussman, David
    Park, Amy J.
    Chermansky, Christopher
    Nguyen, Victor
    Tung, Amy
    Gillard, Patrick
    Lalla, Anjana
    Nitti, Victor
    NEUROUROLOGY AND URODYNAMICS, 2021, 40 : S157 - S157
12345